21 participants
Neoadjuvant Anti-PD-1 Antibody SHR-1210 and Radiation in Resectable Esophageal Squamous Cell Carcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2017-08-07
- Start Date:
- 2017-08-10
- Completion:
- 2018-06-30
Conditions
- Esophageal Neoplasms
- Esophageal Diseases
Interventions
- RADIATION
- DRUG
No Results Yet